Abstract

In Vitro Transdermal Diffusion of Zileuton from a Topical Gel

Author(s): Bigeleisen Paul E

Issue: Sep/Oct 2006 - Dermatology

Page(s): 392-395

Download in electronic PDF format for $75
  • In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Page 1
  • In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Page 2
  • In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Page 3
  • In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Page 4

Abstract

Zileuton, a leukotriene inhibitor used to treat asthma, is usually administered via the oral route. A transdermal drug delivery system for zileuton was developed for this study. A vertical diffusion cell and freshly harvested human skin were used to test the system. Thirteen percent (3.3 mg) of the drug was delivered into the dermis within 24 hours, and 13.6% (3.3 mg) of the drug was delivered through the epidermis into the receiving chamber of the diffusion cell within 24 hours. A specially constructed transdermal zileuton gel delivered 13.1% (3.3 mg) of the drug through the epidermis into the receiving chamber within 24 hours. These results are predictive of the successful use of zileuton as a transdermal gel in human subjects.

Related Keywords

  • zileuton
  • leukotriene inhibitor
  • asthma
  • topical preparations
  • transdermal administration
  • skin diffusion

Related Categories

  • EXCIPIENTS
  • PEER-REVIEWED
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS
  • RESPIRATION/LUNG/BREATHING

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Sep/Oct 2006
Pg. 392-395
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Author(s): Bigeleisen Paul E
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Nov/Dec 2014
Pg. 512-515
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Mar/Apr 2021
Pg. 146-155
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Sep/Oct 2023
Pg. 424-430
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Author(s): Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Nov/Dec 2014
Pg. 504-511
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Mar/Apr 2015
Pg. 161-166
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2020
Pg. 163-167
Feasibility Study of Asthma Cream
Author(s): Kuang Andrew
Mar/Apr 2015
Pg. 167-173
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Author(s): Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
May/Jun 2011
Pg. 200-203
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Author(s): Wynn Tom, Goetsch Daniel
Mar/Apr 2012
Pg. 110-114
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Author(s): Griffee Chris, Delano Amy
May/Jun 2004
Pg. 206-209
Basics of Compounding for Cold Sores or Fever Blisters
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 422-426
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Author(s): Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
Nov/Dec 2022
Pg. 490-495
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 131
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 181-184
Transdermal Gel in the Treatment of Postoperative Pain
Author(s): Alexander Kayla, Wynn Tom
Mar/Apr 2011
Pg. 157
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Author(s): Allen Loyd V Jr